Hepatitis C virus core protein substitutions affect the response to pegylated-interferon and ribavirin therapy

BMC Genomics

Poster Presentation

Fatimah S. Alhamlan¹  Nisreen Z. Khalaf¹  Ahmed A. Al-Qahtani²  Mohammed N. Al-Ahdal³  Hamad I. Al-Ashgar⁴  Faisal Sanai⁵  Ayman A. Abdo⁶ 

[1] Department of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia;Department of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia;Department of Microbiology and Immunology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia;Liver Disease Research Center, King Saud University, Riyadh, Saudi Arabia;Department of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia;Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia;Department of Microbiology and Immunology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia;Department of Medicine, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia;Hepatobiliary Sciences and Liver Transplantation, King Abdulaziz Medical City, Riyadh, Saudi Arabia;Liver Disease Research Center, King Saud University, Riyadh, Saudi Arabia;Section of Gastroenterology, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia;

关键词: Core Protein;    Virus Core;    Advanced Software;    Protein Substitution;    Saudi Population;   

DOI  :  10.1186/1471-2164-15-S2-P5

来源: Springer

【 授权许可】

Unknown   
© Alhamlan et al; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.